HOME > COMMENTARY
COMMENTARY
-
BARKER ON DRUGS(4)
April 22, 2002
-
Drastically Changing Marketing Strategy - The Best Strategy for Company Differentiation -
April 22, 2002
-
BARKER ON DRUGS (3)
March 11, 2002
-
BARKER ON DRUGS
February 18, 2002
-
Comarketing as a Marketing Strategy Option -1-
January 21, 2002
-
Comarketing as a Marketing Strategy Option -2-
January 21, 2002
-
Barker on Drugs (1)
January 14, 2002
-
Why Foreign-affiliated Companies Cannot Expand Their Market Share in Japan
July 9, 2001
-
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -2-
May 21, 2001
-
< Special Contribution >What Are the Requirements for a Japanese Blockbuster Product? -1-
May 21, 2001
-
Forecasting JapaneseDrug Industry Growth in FY2001
March 26, 2001
-
-1-
February 26, 2001
-
-2-
February 26, 2001
-
-1-
February 5, 2001
-
-2-
February 5, 2001
-
Advanced Technology and Segmentation of Companies
January 15, 2001
-
Don't Write Us Oldies Off!
January 15, 2001
-
Changing Japanese Heathcare Scene - Health Care Transition Leads Evaluation of Pharma Market -
January 15, 2001
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
